Volatile Organic Compound Exposure Tied to Higher Risk of Overactive Bladder

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

MONDAY, July 1, 2024 -- High exposure to volatile organic compounds (VOCs) is independently and positively associated with overactive bladder (OAB) risk, according to a study published online June 6 in Frontiers in Public Health.

Dawen Zhang, from the Fifth People's Hospital of Wujiang District in Suzhou, China, and colleagues investigated the relationship between blood VOCs and OAB risk. Analysis included data from 11,183 participants in the U.S. National Health and Nutrition Examination Survey (2007 to 2020).

The researchers found that when adjusting for potential confounders, blood 2,5-dimethylfuran (adjusted odds ratio [aOR], 2.940), benzene (aOR, 1.460), and furan (aOR, 9.426) were positively independently associated with the risk of OAB in a dose-response manner. Exposure to mixed blood VOCs heightened risk of OAB (OR, 1.29), with furans having the greatest weight. OAB was more susceptible to blood VOCs in young and middle-aged, male, nonhypertensive, and alcohol-drinking populations.

"The concentration association between blood 2,5-dimethylfuran, benzene, and furan and OAB risk suggests that long-term exposure to VOCs may lead to an increased risk of OAB," the authors write. "More prospective and experimental studies are needed to further validate the conclusions of this study and explore the pathological mechanisms."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-02 05:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords